HOWARD E. HEYER, M.D.; FORD K. HICK, M.D., Ph.D.
This content is PDF only. Please click on the PDF icon to access.
The advent of new chemo-therapeutic agents has provided the physician weapons with which to combat infectious endocarditis. While the majority of cases treated with sulfanilamide and its derivatives progress to a fatal issue, a definite minority have been shown to reach a stage of apparent clinical cure. Thirty-one cases which have been cured by the use of sulfanilamide and its derivatives have been gathered from the literature. For convenience the essential data have been collected in tabular form (chart 1). Undoubtedly, other additions will be made as chemotherapy becomes a more generally utilized means of treatment. In addition to the
HEYER HE, HICK FK. EXPERIENCES IN THE TREATMENT OF SUBACUTE BACTERIAL ENDOCARDITIS WITH SULFANILAMIDE, SULFAPYRIDINE AND SULFATHIAZOLE; A REVIEW OF PREVIOUSLY REPORTED CURED CASES WITH THE REPORT OF FIFTEEN TREATED CASES INCLUDING ONE CURE AND ONE ABORTED CASE1. Ann Intern Med. ;15:291–303. doi: 10.7326/0003-4819-15-2-291
Download citation file:
Published: Ann Intern Med. 1941;15(2):291-303.
Cardiology, Endocarditis, Infectious Disease, Streptococcal Infections.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use